P0320 : Targeting TGF-beta I with the transforming growth factor receptor type I kinase inhibitor, LY2157299, modulates stemness-related biomarkers in hepatocellular carcinoma

Authors :: B. Rani
Y. Cao
Steven Dooley
Gianluigi Giannelli
Aristidis Moustakas
Francesco Dituri
Ulla Engström
Luigi Lupo
Source :: Journal of Hepatology. 62:S429
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.
Abstract: Targeting Tgf-Beta I With The Transforming Growth Factor Receptor Type I Kinase Inhibitor, Ly2157299, Modulates Stemness-Related Biomarkers In Hepatocellular Carcinoma

Subjects :: Oncology
medicine.medical_specialty
Hepatology
Kinase
business.industry
Receptor type
medicine.disease
Internal medicine
Hepatocellular carcinoma
TGF beta signaling pathway
medicine
Cancer research
business
Transforming growth factor

Tools